Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelligent Bio Solutions Inc INBS

Healthcare Medical Devices
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat... see more

Recent & Breaking News (NDAQ:INBS)

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement

GlobeNewswire March 1, 2023

Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge

GlobeNewswire February 16, 2023

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights

GlobeNewswire February 14, 2023

Intelligent Bio Solutions Inc. Announces Reverse Stock Split

GlobeNewswire February 9, 2023

Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing

GlobeNewswire February 7, 2023

Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests

GlobeNewswire January 31, 2023

Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development

GlobeNewswire January 23, 2023

Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering

GlobeNewswire December 22, 2022

Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders

GlobeNewswire December 21, 2022

Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights

GlobeNewswire November 9, 2022

Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations

GlobeNewswire November 7, 2022

Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing

GlobeNewswire November 3, 2022

Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9

GlobeNewswire November 2, 2022

Intelligent Bio Solutions Inc. Announces Leading U.K. Container Haulier Switching to Fingerprint Drug Screening System for In-house Testing

GlobeNewswire October 31, 2022

GBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (IBSS) and Announces Key Executive Appointments

GlobeNewswire October 26, 2022

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

GlobeNewswire October 4, 2022

GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights

GlobeNewswire August 31, 2022

GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31

GlobeNewswire August 29, 2022

GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood

GlobeNewswire July 13, 2022

GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus

GlobeNewswire June 23, 2022